Stocks that traded heavily or had substantial price changes Monday:

Meredith Corp., up $4.11 to $35.21.

The publisher of Better Homes and Gardens is selling its local media group to Gray Television for $2.7 billion.

Dell Technologies Inc., down 55 cents to $97.78.

The computer and technology services provider is selling its Boomi cloud-based platform to private equity firms for about $4 billion.

Ocugen Inc., up $3.01 to $15.68.

The drug developer reported encouraging study results for a potential COVID-19 vaccine it is developing with Bharat Biotech.

Penn National Gaming Inc., up $1.35 to $90.47.

The casino and racetrack operator is creating a team to develop internet casino content.

Schlumberger NV, up $1.17 to $28.22.

Arabian Drilling Co., a Saudi oilfield-services company partly held by Schlumberger, is reportedly preparing an initial public offering.

PetMed Express Inc., up 5 cents to $29.48.

The pet pharmacy raised its quarterly dividend.

Moderna Inc., up $7.20 to $186.02.

The biotechnology company signed a deal with Switzerland-based Gavi to supply up to 500 million doses of its COVID-19 vaccine.

Estee Lauder Companies Inc., down $24.87 to $288.93.

The owner of Clinique and other beauty brands reported weak fiscal third-quarter revenue.

Get Unlimited Access
$3 for 3 Months
Subscribe Now

After the initial selected subscription period your subscription rate will auto renew at $8.00 per month.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.